A Study to Evaluate the Mass Balance of 14C-Napabucasin in Healthy Adult Male Subjects
Clinical trial NCT03525405 · COMPLETED
Trial details
- NCT number
- NCT03525405
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-18
- Primary completion
- 2018-06-02
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.